DCE MRI in Patients With Pancreatic Cancer

NCT02070705 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

77

Enrollment

OTHER

Sponsor class

Stopped Loss of funding

Conditions

Familial Pancreatic Cancer
Pancreatic Adenocarcinoma
Pancreatic Intraductal Papillary-Mucinous Neoplasm

Interventions

PROCEDURE: Dynamic Contrast-Enhanced Magnetic Resonance Imaging
DRUG: Ferumoxytol

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]